ph: 09 535 7218
FILTERED BY TAG:

Hep C

X

Hepatitis C Treatment - Update to pathway and claiming process

The Chronic Hepatitis C pathway has been updated for the newly funded direct acting antiviral (DAA) medication, Maviret™. Maviret™ is the recommended treatment in primary care for a majority of patients with Hepatitis C who do not have cirrhosis: Cure rate of 99%...
Read more and comment
 

This product has been added to your cart

CHECKOUT